Literature DB >> 15065215

Reference distributions for alpha2-macroglobulin: a practical, simple and clinically relevant approach in a large cohort.

Robert F Ritchie1, Glenn E Palomaki, Louis M Neveux, Olga Navolotskaia, Thomas B Ledue, Wendy Y Craig.   

Abstract

In this 11th article in a series, reference values of serum levels alpha(2)-macroglobulin alpha(2)M) are examined. The study is based on a cohort of 40,420 Caucasian individuals from northern New England that were tested in our laboratory between 1994 and 2000. Measurements were standardized against Certified Reference Material (CRM 470)/Reference Preparation for Proteins in Human Serum (RPPHS) and the results analyzed using a previously described statistical approach. Individuals with unequivocal laboratory evidence of inflammation (C-reactive protein >10 mg/L) were excluded in one leg of the study and included in the other, confirming that alpha(2)M does not respond to acute phase drive in man. Nephrotic syndrome, diabetes mellitus, and chronic liver disease have significant effect on levels of alpha(2)M. Dramatic changes occur during life with males higher from birth to age 12, females thereafter have higher values until the ninth decade. When values were expressed as multiples of the age- and gender-specific median levels, the resulting distributions fitted a log-Gaussian distribution well over a broad range. When patient data are normalized in this manner, the distribution parameters can be used to assign a centile corresponding to an individual's measurement thus simplifying interpretation. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15065215      PMCID: PMC6807892          DOI: 10.1002/jcla.20012

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  61 in total

1.  Hereditary alpha 2-macroglobulin deficiency.

Authors:  D Bergqvist; I M Nilsson
Journal:  Scand J Haematol       Date:  1979-11

Review 2.  The nephrotic syndrome at presentation of insulin-dependent diabetes mellitus; cause or coincidence?

Authors:  T L Dornan; S Jenkins; R E Cotton; R B Tattersall; R P Burden
Journal:  Diabet Med       Date:  1988 May-Jun       Impact factor: 4.359

3.  Alpha2-macroglobulin in diabetes.

Authors:  D E McMillan
Journal:  Lancet       Date:  1976-11-06       Impact factor: 79.321

4.  Serum protein fractions. Effects of oral contraceptives and pregnancy.

Authors:  S Ramcharan; E E Sponzilli; J C Wingerd
Journal:  Obstet Gynecol       Date:  1976-08       Impact factor: 7.661

5.  Inhibition of mutalysin II, a metalloproteinase from bushmaster snake venom by human alpha2-macroglobulin and rabbit immunoglobulin.

Authors:  C T Souza; M B Moura; A Magalhaes; L G Heneine; C C Olortegui; C R Diniz; E F Sanchez
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2001-09       Impact factor: 2.231

6.  A study of plasma alpha-2-macroglobulin levels in type 2 diabetic subjects with microalbuminuria.

Authors:  J Ahmad; M Singh; M Saleemuddin
Journal:  J Assoc Physicians India       Date:  2001-11

Review 7.  Management of steroid-sensitive nephrotic syndrome in children with type 1 diabetes.

Authors:  Michael Goldman; Diane Hébert; Denis F Geary
Journal:  Pediatr Nephrol       Date:  2002-05       Impact factor: 3.714

8.  Renal disease in diabetics--which patients have diabetic nephropathy and what is their outcome?

Authors:  K L Lynn; T J Frendin; R J Walker; R R Bailey; C P Swainson
Journal:  Aust N Z J Med       Date:  1988-10

9.  Albumin, prealbumin, transferrin and serum proteinase inhibitors in asymptomatic and hospitalized Thai alcohol drinkers.

Authors:  P Pongpaew; F P Schelp
Journal:  J Stud Alcohol       Date:  1983-03

10.  Serum and sputum alpha 2 macroglobulin in patients with chronic obstructive airways disease.

Authors:  D Burnett; R A Stockley
Journal:  Thorax       Date:  1981-07       Impact factor: 9.139

View more
  8 in total

1.  Biochemical Foundations of Health and Energy Conservation in Hibernating Free-ranging Subadult Brown Bear Ursus arctos.

Authors:  Karen Gjesing Welinder; Rasmus Hansen; Michael Toft Overgaard; Malene Brohus; Mads Sønderkær; Martin von Bergen; Ulrike Rolle-Kampczyk; Wolfgang Otto; Tomas L Lindahl; Karin Arinell; Alina L Evans; Jon E Swenson; Inge G Revsbech; Ole Frøbert
Journal:  J Biol Chem       Date:  2016-09-08       Impact factor: 5.157

2.  Prediction for steatosis in type-2 diabetes: clinico-biological markers versus 1H-MR spectroscopy.

Authors:  Boris Guiu; Elodie Crevisy-Girod; Christine Binquet; Laurence Duvillard; David Masson; Côme Lepage; Samia Hamza; Denis Krausé; Bruno Verges; Anne Minello; Jean-Pierre Cercueil; Patrick Hillon; Jean-Michel Petit
Journal:  Eur Radiol       Date:  2011-11-20       Impact factor: 5.315

3.  Reference distributions for apolipoproteins AI and B and the apolipoprotein B/AI ratios: a practical and clinically relevant approach in a large cohort.

Authors:  Robert F Ritchie; Glenn E Palomaki; Louis M Neveux; Thomas B Ledue; Wendy Y Craig; Santica Marcovina; Olga Navolotskaia
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

4.  Acute phase proteins are major clients for the chaperone action of α₂-macroglobulin in human plasma.

Authors:  Amy R Wyatt; Nathan W Zammit; Mark R Wilson
Journal:  Cell Stress Chaperones       Date:  2012-08-16       Impact factor: 3.667

5.  Proteomic analysis of synovial fluid from rheumatic arthritis and spondyloarthritis patients.

Authors:  Svend Birkelund; Tue Bjerg Bennike; Kenneth Kastaniegaard; Mads Lausen; Thomas Bouet Guldbæk Poulsen; Tue Wenzel Kragstrup; Bent Winding Deleuran; Gunna Christiansen; Allan Stensballe
Journal:  Clin Proteomics       Date:  2020-08-06       Impact factor: 3.988

Review 6.  Reference distributions for alpha2-macroglobulin: a comparison of a large cohort to the world's literature.

Authors:  Robert F Ritchie; Glenn E Palomaki; Louis M Neveux; Olga Navolotskaia
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

7.  Cardiac isoform of alpha 2 macroglobulin: a marker of cardiac involvement in pediatric HIV and AIDS.

Authors:  Ramachandran Meenakshisundaram; Shah Sweni; Ponniah Thirumalaikolundusubramanian
Journal:  Pediatr Cardiol       Date:  2010-02       Impact factor: 1.655

8.  A score derived from routine biochemical parameters increases the diagnostic accuracy of chromogranin A in detecting patients with neuroendocrine neoplasms.

Authors:  Ivan Kruljac; Ivan Vurnek; Sebastian Maasberg; Davor Kust; Kristina Blaslov; Blaženka Ladika Davidović; Mario Štefanović; Alma Demirović; Alen Bišćanin; Jakša Filipović-Čugura; Jasmina Marić Brozić; Ulrich-Frank Pape; Milan Vrkljan
Journal:  Endocrine       Date:  2018-04-09       Impact factor: 3.633

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.